Tolerability, Safety and Pharmacokinetic Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Psoriasis

NCT02649270 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped company strategy

Conditions

Psoriasis

Interventions

BIOLOGICAL: T1h

Sponsor

Biotech Pharmaceutical Co., Ltd.